Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Seminars in Arthritis and Rheumatism
Published July 28, 2026
Disentangling the hepatic risks of familial Mediterranean Fever and colchicine: A propensity scor...
August 7, 2026
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published August 6, 2026
00:00
--:--
EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosi...
August 7, 2026
Share
EXTL3 dysfunction identified as a driver of aberrant bone development in severe familial ankylosing spondylitis
https://www.medspoke.co/channel_playlist?object_id=123&tap_id=13350
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published August 6, 2026
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patien...
August 7, 2026
Why are you reporting this TALK?
